| Literature DB >> 24984936 |
Jason Gavenonis1, Nicholas E Jonas1, Joshua A Kritzer2.
Abstract
Hsp90 is a molecular chaperone implicated in many diseases including cancer and neurodegenerative disease. Most inhibitors target the ATPase site in Hsp90's N-terminal domain, with relatively few inhibitors of other domains reported to date. Here, we show that peptides derived from a short helix at the C-terminus of Hsp90 show micromolar activity as Hsp90 inhibitors in vitro. These inhibitors do not block the N-terminal domain's ATP-binding site, and thus are likely to bind at the C-terminal domain. Substitutions and helix stapling were applied to demonstrate structure-activity relationships and improve activity. These helical peptides will help guide the design of a new class of inhibitors of Hsp90's C-terminal domain.Entities:
Keywords: Hsp90; Molecular chaperones; Peptides; Protein–protein interactions; Stapled helices
Mesh:
Substances:
Year: 2014 PMID: 24984936 PMCID: PMC4847944 DOI: 10.1016/j.bmc.2014.06.006
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641